AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Takeaway:
(HAL) is showing a weak technical profile with no indicators and 3 bearish signals in the last 5 days. The stock carries an internal diagnostic score of 1.69 (0-10), signaling a "technical face-off" with downside risks. Meanwhile, fundamentals are mixed, and analyst views are diverging.Average Rating Score: The average analyst rating is 3.88. Weighted by historical performance, the score drops to 3.05, showing a bias toward caution among higher-performing analysts.
Rating Consistency: Analysts are highly divided, with ratings ranging from "Strong Buy" to "Neutral." The most active institutions include Wells Fargo (80.0% win rate) and Barclays (42.9% win rate).
Price vs. Analyst Consensus: While analysts are neutral-to-bullish, the recent price trend has been downward (-8.49%), indicating a potential misalignment between market sentiment and technical dynamics.
The internal diagnostic score for fundamentals is 7.35 (0-10), showing mixed signals: strong cash and revenue metrics but weak earnings growth.
Big Money vs. Retail: Halliburton has seen a negative overall fund-flow trend with 78.3% of analysts assigning a "good" flow score (7.83/10). However, large and extra-large institutional investors are split, with large funds showing a positive trend while extra-large ones are negative. Retail investors, on the other hand, have contributed to the overall negative trend (Small trend: negative, Small inflow ratio: 49.79%).
Block investors are also negative (block trend: negative), with a block inflow ratio of 49.54%, showing institutional caution despite a high overall inflow ratio of 49.64%.
Recent Chart Signals (by Date):
Trend Quality: The overall trend is weak and bearish with more bearish indicators (3) than bullish (0). The technical score is 1.69 (0-10), suggesting caution and a high likelihood of downward movement in the near term.
Halliburton is currently facing technical headwinds with a weak score of 1.69 and three bearish indicators in the last five days. Analysts are divided, but the price trend doesn’t align with the overall consensus. While fundamentals remain mixed with strong cash and revenue, earnings growth is sharply negative (-48.59% YoY).
Actionable Takeaway: Given the internal diagnostic scores and the divergence between analyst ratings and price behavior, it may be prudent to wait for a clearer breakout or earnings report before entering. Traders should closely monitor the MACD Death Cross and Williams %R signals for potential short-term volatility.
A quantitative finance AI researcher dedicated to uncovering winning stock strategies through rigorous backtesting and data-driven analysis.

Dec.18 2025

Dec.18 2025

Dec.18 2025

Dec.18 2025

Dec.18 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet